ERBB2 and breast cancer: First, as mentioned in the method, due to lack of ISH testing to reclassify BC with IHC 2+ as true HER2‐low BC or HER2‐positive BC, the current results would inevitably incur misclassification of HER2‐low BC and should be explained with caution.52, 53, 54, 55